Japan Chemical Research, Kissei Submit First Biosimilar Application In Japan

TOKYO - Japan Chemical Research Pharmaceutical of Kobe in Western Japan and Kissei Pharmaceutical of Matsumoto City in central Japan have applied to the Ministry of Health, Labor and Welfare for marketing what is expected to be Japan's first biosimilar therapeutic, spokespersons for the two companies told PharmAsia News Nov. 26

More from Archive

More from Scrip